Skip to main content
. 2023 Oct 30;30(1):218–228. doi: 10.1038/s41591-023-02660-6

Extended Data Fig. 6. PT regression and necrosis in the path-evaluable patient population.

Extended Data Fig. 6

Paired pretreatment and on-treatment %regression-PT and %necrosis-PT in tissue specimens from individual patients by (a) histology (n = 24, squamous; n = 23, nonsquamous) and (b) treatment arm (n = 17, nivolumab plus chemotherapy; n = 30, chemotherapy). PT denotes primary tumor.